Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 0 | 0 | 0 | -7,400 |
| Depreciation Amortization | N/A | 0 | 0 | 0 | 12,480 |
| Other Working Capital | N/A | 0 | 0 | 0 | 7,630 |
| Other Operating Activity | 0 | -20,530 | 5,980 | 0 | -4,140 |
| Operating Cash Flow | $N/A | $-20,530 | $5,980 | $0 | $8,570 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -8,490 | -17,300 | 0 | -23,590 |
| Net Acquisitions | N/A | 0 | 0 | 0 | 1,910 |
| Other Investing Activity | 0 | -11,940 | -4,190 | 0 | -2,710 |
| Investing Cash Flow | $N/A | $-20,430 | $-21,490 | $0 | $-24,390 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 65,520 | 5,020 | 0 | 14,180 |
| Financing Cash Flow | $N/A | $65,520 | $5,020 | $0 | $14,180 |
| Beginning Cash Position | N/A | 4,820 | 51,950 | 0 | 40,660 |
| End Cash Position | N/A | 29,380 | 41,470 | 0 | 39,020 |
| Net Cash Flow | $N/A | $24,560 | $-10,470 | $0 | $-1,630 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -20,530 | 5,980 | 0 | 8,570 |
| Free Cash Flow | 0 | -20,530 | 5,980 | 0 | 8,570 |